FMAUFetal and Maternal Assessment Unit (pregnancy; UK)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The introduction of new positron-emitting imaging agents such as the cell proliferation markers [F-18]-fluoro-L-thymidine (FLT) (34) and F-18 or C-11-2'-fluoro-5methyl-1-beta-d-arabinofuranosyluracil (FMAU), (35) and [F-18]-fluoromisonidazole, (36) a radiotracer marker for tumor hypoxia, offers new opportunities for evaluating breast cancer and might help achieve this goal.